[INTERVIEW] – Changjin Lee, Senior Researcher, Biosolution Non-Clinical Research Center
“The advanced alternative test method for UV protection developed through the human skin model ‘KeraSkin™’ is a new test evaluation method that overcomes the limitations of animal tests or human phenotype-centered clinical trial evaluation methods. It is expected that the competitiveness of sunscreen in the domestic cosmetics industry will be further developed. In the future, we will screen more sunscreen formulations to improve the accuracy, precision, and sensitivity of our sunscreen effectiveness assessment method.”
Changjin Lee, a senior researcher at the Biosolution Non-Clinical Research Center, explained his poster paper ‘Development of a UV Protection Efficacy Evaluation Method Using a Human Skin Model (KeraSkin™)’. He presented this paper at the ‘2024 Spring Conference’ held by the Korean Society of Cosmetic Sciences (Chairman Park Young-ho) on May 10.
Read more: click here.
Welcome to this 33rd edition of ZOOM, a magazine dedicated to preclinical trials and clinical…
Precision and reliability are essential in dermatology and aesthetics. The Antera 3D CS by Miravex…
PhD Trials, one of the leading CROs for performing in vivo studies with cosmetic products…